M V Sherrid

Summary

Affiliation: St. Luke's-Roosevelt Hospital Center
Country: USA

Publications

  1. ncbi request reprint Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
    Mark V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
    Ann Thorac Surg 75:620-32. 2003
  2. ncbi request reprint Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    JAMA 298:405-12. 2007
  3. ncbi request reprint Medical treatment of hypertrophic cardiomyopathy
    M V Sherrid
    Hypertrophic Cardiomyopathy Program, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, Division of Cardiology, 3B 30, 1000 10th Avenue, New York, NY 10019, USA
    Curr Cardiol Rep 2:148-53. 2000
  4. ncbi request reprint Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy
    M V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Am Coll Cardiol 36:1344-54. 2000
  5. ncbi request reprint Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
    M V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY 10019, USA
    Circulation 97:41-7. 1998
  6. ncbi request reprint Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment
    Dan Musat
    Hypertrophic Cardiomyopathy Program, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:9-17. 2006
  7. ncbi request reprint Echocardiography in the treatment of hypertrophic cardiomyopathy
    Dan Musat
    Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:18-26. 2006
  8. ncbi request reprint Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?
    Atul Kukar
    Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Anadolu Kardiyol Derg 6:49-54. 2006
  9. ncbi request reprint Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy
    Ivan Barac
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
    J Am Coll Cardiol 49:1203-11. 2007
  10. ncbi request reprint Hypertrophic cardiomyopathy: through a window of 50 years
    Mark V Sherrid
    Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:1-2. 2006

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
    Mark V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
    Ann Thorac Surg 75:620-32. 2003
    ..Echocardiography has become central to understanding this complex phenomenon, and for clinical diagnosis, operative planning and intraoperative management...
  2. ncbi request reprint Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    JAMA 298:405-12. 2007
    ..However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved...
  3. ncbi request reprint Medical treatment of hypertrophic cardiomyopathy
    M V Sherrid
    Hypertrophic Cardiomyopathy Program, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, Division of Cardiology, 3B 30, 1000 10th Avenue, New York, NY 10019, USA
    Curr Cardiol Rep 2:148-53. 2000
    ..The mechanism of benefit of negative inotropes for obstruction is described, and newer agents under investigation are discussed. Finally, antiarrhythmic therapy for troubling atrial and ventricular arrhythmias is considered...
  4. ncbi request reprint Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy
    M V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Am Coll Cardiol 36:1344-54. 2000
    ..The purpose of this study was to determine whether the dynamic cause for mitral systolic anterior motion (SAM) is a Venturi or a flow drag (pushing) mechanism...
  5. ncbi request reprint Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
    M V Sherrid
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY 10019, USA
    Circulation 97:41-7. 1998
    ..Drugs with negative inotropic effect are widely used to decrease obstruction in hypertrophic cardiomyopathy (HCM). However, the mechanism of therapeutic benefit has not been studied...
  6. ncbi request reprint Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment
    Dan Musat
    Hypertrophic Cardiomyopathy Program, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:9-17. 2006
    ..Most symptomatic HCM patients with significant obstruction at rest or provocation can be successfully managed with long-term medication alone...
  7. ncbi request reprint Echocardiography in the treatment of hypertrophic cardiomyopathy
    Dan Musat
    Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:18-26. 2006
    ..Echocardiography is a valuable tool to choose the site of ablation (using myocardial contrast echocardiography), as well as for evaluation of results...
  8. ncbi request reprint Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?
    Atul Kukar
    Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Anadolu Kardiyol Derg 6:49-54. 2006
    ..Future investigations will determine if alternate forms of pacing, including left atrial or left ventricular pacing, may improve objective measures in these patients...
  9. ncbi request reprint Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy
    Ivan Barac
    Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
    J Am Coll Cardiol 49:1203-11. 2007
    ..We investigated the cause of the midsystolic drop (MSD) in left ventricular (LV) ejection velocities that are observed with hypertrophic cardiomyopathy (HCM) and severe obstruction...
  10. ncbi request reprint Hypertrophic cardiomyopathy: through a window of 50 years
    Mark V Sherrid
    Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York City, NY, USA
    Anadolu Kardiyol Derg 6:1-2. 2006
  11. ncbi request reprint Pathophysiology and treatment of hypertrophic cardiomyopathy
    Mark V Sherrid
    Hypertrophic Cardiomyopathy Program and Echocardiography Laboratory, Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Prog Cardiovasc Dis 49:123-51. 2006
    ..Bacterial endocarditis prophylaxis is recommended. Patients are advised to avoid athletic competition and extremes of physical exertion. First degree family members should be screened with echocardiography and ECG...
  12. ncbi request reprint Hypertrophic cardiomyopathy with massive midventricular hypertrophy, midventricular obstruction and an akinetic apical chamber
    Karl Duncan
    Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, USA
    Anadolu Kardiyol Derg 6:279-82. 2006
  13. ncbi request reprint Unusual anomalous single papillary muscle causing symptomatic mid-left ventricular cavity obstruction: octopus papillary muscle
    Ajay S Shah
    St Luke s Roosevelt Hospital Center, New York, New York 10019, USA
    J Am Soc Echocardiogr 19:939.e9-11. 2006
    ..The papillary muscle and the arms divided the left ventricle into apical and subaortic chambers. Flow communicated between the two chambers through multiple openings between the arms with a systolic peak Doppler gradient of 50 mm Hg...
  14. ncbi request reprint Beyond extended myectomy for hypertrophic cardiomyopathy: the resection-plication-release (RPR) repair
    Sandhya K Balaram
    Division of Cardiothoracic Surgery, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10025, USA
    Ann Thorac Surg 80:217-23. 2005
    ..We sought to investigate the medium-term success of this three-step repair that addresses all aspects of complex HCM pathology...
  15. ncbi request reprint Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
    Mark V Sherrid
    St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
    J Am Coll Cardiol 45:1251-8. 2005
    ..In this study we assessed the long-term efficacy and safety of disopyramide for patients with obstructive hypertrophic cardiomyopathy (HCM)...
  16. ncbi request reprint Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 60, Minneapolis, MN 55407, USA
    J Am Coll Cardiol 41:974-80. 2003
    ..The goal of this study was to determine the impact of race on identification of hypertrophic cardiomyopathy (HCM)...
  17. doi request reprint Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting
    Tseday E Sirak
    Division of Cardiology, Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY 10019, USA
    Chest 133:1243-6. 2008
    ..Two and a half hours after oral administration of disopyramide, LVOT gradient had decreased to 25 mm Hg with a corresponding immediate improvement in symptoms...